Big Pharma company Pfizer recently bought another pharmaceutical company specializing in producing heart medication. Coincidentally, some of these heart medications can counteract the heart problems caused by Pfizer’s Wuhan coronavirus (COVID-19) mRNA vaccine.
Pfizer recently signed an agreement with Arena Pharmaceuticals to purchase the company. Arena is a clinical-stage biopharmaceutical firm based in San Diego that specializes in developing immuno-inflammatory treatments. At the time of its acquisition, Arena was also expanding its capabilities “to study cardiovascular conditions like acute heart failure and microvascular obstruction.”
To fund the acquisition of Arena, Pfizer is dipping into the nearly $28 billion in cash it has received from the sale of its mRNA COVID-19 vaccine. The boards of directors of both companies have unanimously approved the transaction although Pfizer’s acquisition still has to be cleared by regulators.Pfizer buys pharmaceutical company that makes heart medication to solve the problem caused by mRNA vaccines – Dr. Eddy Bettermann MD